Company Profile
Cryo-Cell Stock Price, News & Catalysts
- Ticker:
- CCEL
- Exchange:
- AMEX
- Sector:
- Biopharma
- Location:
- United States
Stock performance
4.56 USD (+9.09%)
Close
Last updated: August 21, 2026
27.3M USD
Market cap
Why the stock is moving
As of Aug 21, 2026, CCEL closed up 9.09% at $4.56. No new same-company headline was identified in the current news window.
Company overview
Cord Blood and Tissue Banking
Cryo-Cell International, founded in 1989, is one of the earliest private cord blood banks. Together with affiliated organizations, it has stored more than 250,000 cord blood and cord tissue samples, generating revenue from processing and long-term storage services.
Private Family Banking
Cryo-Cell’s core service allows families to preserve newborn cord blood and cord tissue for potential future medical use. Revenue includes initial collection and processing fees as well as recurring long-term storage fees.
Public Cord Blood Banking
Cryo-Cell also operates a public banking program with Duke University and maintains a donation site at Cedars-Sinai Medical Center. The public bank has supported more than 900 transplants.
Quality Systems and Processing Technology
The company’s facilities are FDA-registered, operate under cGMP and cGTP standards, and hold multiple state licenses and quality accreditations, including AABB and FACT. Cryo-Cell also holds exclusive rights to PrepaCyte-CB, its advanced cord blood processing technology.
Future catalysts
- Cryo-Cell’s catalysts are cord-blood banking, fertility services, and steady recurring consumer-health demand. The company moves more on operations than on binary events.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Cryo-Cell (CCEL)?
Cryo-Cell (CCEL) most recently closed at 4.56 USD, a +9.09% move versus the previous session.
What is the market cap of Cryo-Cell (CCEL)?
Cryo-Cell currently has a market capitalization of 27.3M USD on BioPharmSignal.
What does Cryo-Cell do?
Cord Blood and Tissue Banking Cryo-Cell International, founded in 1989, is one of the earliest private cord blood banks. Together with affiliated organizations, it has stored more than 250,000 cord blood and cord tissue samples, generating revenue from processing and long-term storage services. Private Family Banking Cryo-Cell’s core service allows families...
On which exchange is CCEL stock listed?
Cryo-Cell (CCEL) is associated with AMEX, United States, Biopharma.
What is Cord?
Cryo-Cell’s catalysts are cord-blood banking, fertility services, and steady recurring consumer-health demand.
Which conditions is Cryo-Cell targeting with Cord?
Cryo-Cell’s catalysts are cord-blood banking, fertility services, and steady recurring consumer-health demand.
How does Cryo-Cell describe recent progress with Cord?
Cryo-Cell’s catalysts are cord-blood banking, fertility services, and steady recurring consumer-health demand.
What is Blood?
Cord Blood and Tissue Banking Cryo-Cell International, founded in 1989, is one of the earliest private cord blood banks.